JPRN-jRCT2080221341未知3 期
A clinical study of KRN321 in pediatric patients with chronic kidney disease
Kyowa Hakko Kirin Co., Ltd.0 个研究点开始时间: 2010年12月24日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 2age old 至 <= 18age old（—）
- 性别
- All
入选标准
- •Written informed consent from guardian
- •- ND patients (diagnosed with CKD and not receiving hemodialysis), PD patients (receiving peritoneal dialysis), or HD patients (receiving hemodialysis once a week or over)
排除标准
- •- Uncontrolled hypertension
- •- Congestive heart failure
- •- Malignant tumor, hematological disease or hemorrhagic lesion
- •- Within 16 weeks preceding the study, excessive bleeding or blood transfusion associated with surgical operation etc.
- •- Serious allergy (include drug hypersensitivity)
- •- Hypersensitivity for rHuEPO agents
研究者
相似试验
已完成
3 期
Phase 3 study of KCI002 in pediatric patientsConstipationJPRN-jRCT2080224936Kyowa Chemical Industry Co., Ltd.60
招募中
3 期
Phase 3 study2 of KCI002 in pediatric patientsConstipationJPRN-jRCT2031220631Yoshimura Yuya50
已完成
4 期
Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLHX-linked Hypophosphatemia (XLH)NCT04842032Kyowa Kirin Co., Ltd.28
未知
3 期
A phase III study of KW-3357JPRN-jRCT2080221497Kyowa Hakko Kirin Co., Ltd.
未知
3 期
A phase III study of KW-3357JPRN-jRCT2080221496Kyowa Hakko Kirin Co., Ltd.